Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

October 2013

Fecal Bacteriotherapy Now Covered with Prior Authorization 

Effective January 1, 2014, Harvard Pilgrim will begin covering medically necessary fecal bacteriotherapy for members of our HMO, POS, or PPO products who have been diagnosed with severe, recurrent Clostridium difficile, provided a prior authorization is obtained.

With prior authorization, coverage will include assessment of a healthy donor specimen, preparation of fecal microbiota for instillation, and instillation of fecal microbiota solution derived from donor’s fecal matter. Please be sure to use code G0455 when requesting authorization.

Instillation of fecal bacteriotherapy via colonoscope is authorized when healthy donor stool is available for transplant, and there is medical record documentation confirming the member has had:

  • Three or more episodes of Clostridium difficile, confirmed by positive stool tests; and
  • Recurrent and/or persistent Clostridium difficile after at least two courses of antibiotic therapy (for example, metronidazole or vacomycin for the first episode, pulsed vancomycin for the second).

To obtain prior authorization, providers must submit the required written information and meet the criteria as specified in the Fecal Bacteriotherapy Medical Review Criteria.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version


Medicare Advantage StrideSM (HMO) Plans Offered in January

Harvard Pilgrim #1 for 10th Year in a Row

Pediatric Dental and Vision Coverage

Harvard Pilgrim Collaborates on New Hampshire Medicaid Program


Specialty Pharmacy Name Change

Prior Authorization for Cinryze

P&T Committee Updates

Fecal Bacteriotherapy Now Covered with Prior Authorization

HEDIS Spotlight: Follow-up Care for Children Taking ADHD Medication

Recognizing Social Phobia in the Primary Care Setting

Reminder: Synagis for the Upcoming RSV Season


C Codes Now Accepted

Outpatient Fee Schedule Updates

2014 CPT and HCPCS codes

Change in Proration for Inpatient Stays with Partial Eligibility

Reminder: HPHConnect Account Revalidation


Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,

Kristin Edmonston,
Production Coordinator